Skip to content

13F-HR filed by Euclidean Capital LLC

Euclidean Capital LLC filed this 13F-HR for the quarter ended 2022-12-31, filed 2023-02-14, with 11 holding rows worth $106,883,090.

Accession
0001012975-23-000092
Filed
2023-02-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2022

A holdings report, 11 entries on the cover page, a total value of $106,883,090 stated on the cover page (in dollars after the unit check, H1), rows summing to $106,883,090 with VALUE read as dollars as filed, 13F file number 028-20777. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ISHARES TR46429B598MSCI INDIA ETF577,144$24,089,991dollars as filed
23ANDME HOLDING CO90138Q108CLASS A COM10,243,122$22,125,144dollars as filed
PMV PHARMACEUTICALS INC69353Y103COM2,336,909$20,331,108dollars as filed
ALECTOR INC014442107COMMON STOCK980,894$9,053,652dollars as filed
RAPT THERAPEUTICS INC75382E109COM432,900$8,571,420dollars as filed
FOGHORN THERAPEUTICS INC344174107COMMON STOCK1,261,261$8,046,845dollars as filed
ORIC PHARMACEUTICALS INC68622P109COM747,550$4,403,070dollars as filed
1ST FINL BANCORP320209109COM173,576$4,205,746dollars as filed
NGM BIOPHARMACEUTICALS INC62921N105COM746,674$3,748,303dollars as filed
TENAYA THERAPEUTICS INC87990A106COM915,705$1,840,567dollars as filed
Surrozen, Inc.86889P109COM802,963$467,244dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001012975-23-000092this filing2023-02-14acceptance time not in the bulk data set